Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Hubei Huaqiang High-Tech CoSHSE:688151 +3.22%66 EV-to-EBITDA is 62.07 as of Sep. 02, 2026, which is 47% above its 10-year median of 42.33. GuruFocus rates SHSE:688151 with a GF Score™ of 66/100 and a GF Value™ of ¥21.78 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 516 Medical Devices & Instruments companies, Hubei Huaqiang High-Tech Co ranks worse than 91.28% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Hubei Huaqiang High-Tech Co's enterprise value is ¥3,241.0 Mil.
Hubei Huaqiang High-Tech Co's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was ¥52.2 Mil. Therefore, Hubei Huaqiang High-Tech Co's EV-to-EBITDA for today is 62.07.
The historical rank and industry rank for Hubei Huaqiang High-Tech Co's EV-to-EBITDA or its related term are showing as below:
SHSE:688151'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -2336.51 Med: 42.33 Max: 1935.67
Current: 62.07
During the past 9 years, the highest EV-to-EBITDA of Hubei Huaqiang High-Tech Co was 1935.67. The lowest was -2336.51. And the median was 42.33.
SHSE:688151's EV-to-EBITDA is ranked worse than 91.28% of 516
companies
in the Medical Devices & Instruments industry
Industry Median: 14.3
vs SHSE:688151: 62.07
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Hubei Huaqiang High-Tech Co (SHSE:688151) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Hubei Huaqiang High-Tech Co's PE Ratio (TTM) for today is calculated as:
Hubei Huaqiang High-Tech Co's share price for today is ¥16.98.
Hubei Huaqiang High-Tech Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.140.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:688151 vs ISRG, BDX, RMD: EV-to-EBITDA Comparison
For the Medical Instruments & Supplies subindustry, Hubei Huaqiang High-Tech Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hubei Huaqiang High-Tech Co EV-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Hubei Huaqiang High-Tech Co's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Hubei Huaqiang High-Tech Co's EV-to-EBITDA falls into.
Hubei Huaqiang High-Tech Co's current Enterprise Value is ¥3,241.0 Mil.
Hubei Huaqiang High-Tech Co's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥52.2 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hubei Huaqiang High-Tech Co (SHSE:688151) has a EV-to-EBITDA of 62.07 as of Sep. 02, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Hubei Huaqiang High-Tech Co. This is 47% above median its historical median of 42.33. According to the industry distribution chart, Hubei Huaqiang High-Tech Co ranks #471 out of 516 companies in the Medical Devices & Instruments industry, placing it in the top 91.3%.
Is Hubei Huaqiang High-Tech Co's EV-to-EBITDA too high?
Hubei Huaqiang High-Tech Co's current EV-to-EBITDA of 62.07 is 47% above median its 10-year median of 42.33. The Medical Devices & Instruments industry median EV-to-EBITDA is 14.30. Hubei Huaqiang High-Tech Co's value of 62.07 is 334.1% above this industry median. Based on the distribution chart, Hubei Huaqiang High-Tech Co ranks #471 out of 516 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Hubei Huaqiang High-Tech Co has a GF Score™ of 66/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Hubei Huaqiang High-Tech Co's EV-to-EBITDA compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Hubei Huaqiang High-Tech Co ranks #471 out of 516 companies for EV-to-EBITDA. This places Hubei Huaqiang High-Tech Co in the lower half of its industry. The industry median EV-to-EBITDA is 14.30. Hubei Huaqiang High-Tech Co's value of 62.07 is 334.1% above this benchmark. While the company's 10-year median is 42.33 vs. the industry median of 14.30, Hubei Huaqiang High-Tech Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Medical Devices & Instruments company?
The median EV-to-EBITDA among Medical Devices & Instruments companies is 14.30, based on 516 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hubei Huaqiang High-Tech Co's current EV-to-EBITDA of 62.07 is 334.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Hubei Huaqiang High-Tech Co. For the Medical Devices & Instruments industry, the median EV-to-EBITDA is 14.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hubei Huaqiang High-Tech Co's current EV-to-EBITDA is 62.07, which is 47% above median its own 10-year median of 42.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hubei Huaqiang High-Tech Co stock overvalued right now?
Based on GuruFocus' analysis, Hubei Huaqiang High-Tech Co (SHSE:688151) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥21.78, compared to a current price of ¥16.98 — trading 22% below its estimated fair value. The current EV-to-EBITDA is 62.07, which is 47% above median its 10-year median of 42.33 and 334.1% above the Medical Devices & Instruments industry median of 14.30. Hubei Huaqiang High-Tech Co's overall GF Score™ is 66/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Hubei Huaqiang High-Tech Co (SHSE:688151), the current EV-to-EBITDA is 62.07 as of Sep. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hubei Huaqiang High-Tech Co (SHSE:688151) Overvalued in 2026?
Based on GuruFocus' analysis, Hubei Huaqiang High-Tech Co stock appears to be undervalued.
The current stock price of ¥16.98 is trading 22% below its estimated GF Value™ of ¥21.78.
GuruFocus considers Hubei Huaqiang High-Tech Co to be Modestly Undervalued.
Key valuation signals for SHSE:688151:
EV-to-EBITDA: 62.07 (47% above median its 10-year median of 42.33)
GF Value™: ¥21.78 vs. price of ¥16.98 (22% below fair value)
Industry Position: 334.1% above the Medical Devices & Instruments median (#471 of 516)
No single metric tells the full story. See the SHSE:688151 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hubei Huaqiang High-Tech Co Ltd is engaged in the Research, development, production and sales of special protective equipment, pharmaceutical packaging and medical device products.
66GF Score
Get the complete analysis for SHSE:688151
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688151 has been successfully added to your 
